Featured Articles

  1. Real-World Data: Digitalizing A Patient's Prescription Journey In Japan 1/3/2023

    Explore how Japan’s healthcare system provides the most comprehensive RWD by giving access to the complete patient journey through both in- and out-of-hospital pharmacy records as well as personal health records.

  2. How To Run Successful Clinical Trials In Japan 1/3/2023

    Read about why there is no longer any excuse not to include Japan as an integral part of any global clinical-development program for either pharmaceuticals or medical devices. 

  3. How The Fast-Changing R&D Pipeline Is Amplifying The Importance Of Adaptable CROs 1/3/2023

    Find out how major advances in the understanding of the causes of once-untreatable diseases have reshaped the global drug development pipeline over the past decade, paving the way for better health outcomes for many millions of people.

  4. Tailoring Bioanalytical Testing In A New Era Of Drug Development 1/3/2023

    Learn why pharmaceutical companies have to perform a comprehensive battery of tests to ensure product quality, safety, efficacy, purity, and stability through qualitative and quantitative characterization.

  5. Survey Results: Evolving Trends Of Decentralized Clinical Trials In Japan 1/3/2023

    Learn about the decentralized clinical trial initiatives and the trend in Japan, based on the survey CMIC conducted targeting pharmaceutical companies.

  6. The Emergence Of Digital Therapeutics: Building A Future 1/3/2023

    Over time, explore how the data collected by digital therapeutics has the potential to unlock predictive and diagnostic information that will enhance patient outcomes.

  7. Gateways To Asia: Market Access In Japan And South Korea 1/3/2023

    Learn how the recent developments in market access and regulatory rules in Japan and South Korea have paved the way for expansion in Asia.

  8. Another Look At The World's Second-Largest Prescription Drug Market In A Post-Pandemic World 1/3/2023

    Read about why the pharma industry has compelling reasons to include Japan in clinical trials and the country’s responses to the COVID-19 pandemic have only furthered the country’s appeal to the rest of the pharma industry.

  9. How Real-World Data Is Revolutionizing Rare Oncology Drug Development 1/3/2023

    Delve into the challenges and benefits associated with the use of real-world data in the oncology drug development process.

  10. Non-Clinical Studies: The Foundations Of Successful Drug Development 1/3/2023

    Discover how using advanced techniques and analysis methods can predict what a drug candidate’s pharmacokinetic, efficacy, and safety profiles are likely to be in clinical trials.